The landmark STEP 1 trial demonstrated a mean body weight reduction of 14.9% at 68 weeks compared to 2.4% with placebo
Notably, large meta-analyses and collaborative trial datasets have demonstrated no excess risk of severe hypoglycemia, major adverse events, or treatment discontinuation with combination therapy compared with either class alone [11, 28,29,30], supporting the safety and tolerability of combined use in diverse populations
Mindful, slow eating GLP-1 medications like Ozempic act on regions of the brain that regulate appetite, so people taking them become more aware of when they feel full
Trulicity is also a registered trademark of Eli Lilly
Unlock your skins true potential with TAD-600 and embark on a transformative journey toward a more radiant, youthful, and healthier you
Check out the selections in the table below (listed by carbohydrate content, from lowest to highest)